Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000917520-05-000025
Filing Date
2005-02-10
Accepted
2005-02-10 14:22:44
Documents
1
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 dh020405form5_ex.html 5  
1 dh020405form5_ex.xml 5 3392
  Complete submission text file 0000917520-05-000025.txt   5215
Mailing Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Issuer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address
HOLTZ DAVID B (Reporting) CIK: 0001187583 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-26224 | Film No.: 05592272